Integra Lifesciences (IART) Cash flow

257 Followers

Integra Lifesciences Cash Flow

IART's free cash flow for Q4 2025 was $-37.25M. For the 2025 fiscal year, IART's free cash flow was decreased by $-56.02M and operating cash flow was $11.82M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ 50.38M	$ 129.38M	$ 139.96M	$ 264.47M	$ 312.43M
Investing Cash Flow	$ -108.06M	$ -390.81M	$ -94.18M	$ -58.58M	$ -161.44M
Financing Cash Flow	$ 28.34M	$ 237.86M	$ -229.93M	$ -251.95M	$ -98.23M
End Cash Position	$ 235.05M	$ 246.38M	$ 276.40M	$ 456.66M	$ 513.45M
Free Cash Flow	$ -31.05M	$ 24.96M	$ 73.09M	$ 217.38M	$ 264.35M

Currency in USD